Developing effective vaccins against insidous pathogens such as HIV, Mycobacterium tuberculosis and HCV represents a major challenge and is likely to require the induction of potent T cell mediated immune responses. In this project we aim to develop a particulate carrier allowing the selective delivery of both antigens and immunpotentiators to dendritic cells in order to promote the induction of potent T cell mediated immune responses.